We are live on ! Find out more
ABMD

Abiomed Inc
ABMD

Delisted

ABMD was delisted on the 21st of December, 2022.

Back to rankings

527 hedge funds and large institutions have $16B invested in Abiomed Inc in 2018 Q2 according to their latest regulatory filings, with 153 funds opening new positions, 157 increasing their positions, 171 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

428% more first-time investments, than exits

New positions opened: 153 | Existing positions closed: 29

40% more funds holding in top 10

Funds holding in top 10: 15 → 21 (+6)

40% more capital invested

Capital invested by funds: $11.5B → $16B (+$4.55B)

30% more funds holding

Funds holding: 405 → 527 (+122)

8% less repeat investments, than reductions

Existing positions increased: 157 | Existing positions reduced: 171

21% less call options, than puts

Call options by funds: $167M | Put options by funds: $212M

Holders
527
Holders Change
+122
Holders Change %
+30.12%
% of All Funds
12.07%
Holding in Top 10
21
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+40%
% of All Funds
0.48%
New
153
Increased
157
Reduced
171
Closed
29
Calls
$167M
Puts
$212M
Net Calls
-$45.4M
Net Calls Change
-$39.3M

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$297M
2
Two Sigma Advisers
Two Sigma Advisers
New York
+$210M
3
State Street
State Street
Massachusetts
+$158M
4
Renaissance Technologies
Renaissance Technologies
New York
+$146M
5
Two Sigma Investments
Two Sigma Investments
New York
+$138M

Top Sellers

1
BlackRock
BlackRock
New York
-$315M
2
Winslow Capital Management
Winslow Capital Management
Minnesota
-$284M
3
PAI
Palo Alto Investors
California
-$165M
4
William Blair Investment Management
William Blair Investment Management
Illinois
-$154M
5
American Century Companies
American Century Companies
Missouri
-$136M
Name Holding Trade Value Shares
Change 		Change in
Stake
LS
426
Livforsakringsbolaget Skandia
Sweden
$245K +$217K +600 New
VAM
427
Visionary Asset Management
Texas
$243K +$215K +593 New
HighTower Advisors
428
HighTower Advisors
Illinois
$239K +$214K +590 New
MYAM
429
Meiji Yasuda Asset Management
Japan
$233K +$207K +570 New
FA
430
FDx Advisors
Illinois
$232K -$159K -439 -44%
CAM
431
Claret Asset Management
Quebec, Canada
$230K +$204K +563 New
CA
432
Calton & Associates
Florida
$228K +$220K +607 New
AIM
433
Arcadia Investment Management
Michigan
$220K – – –
OTPPB
434
Ontario Teachers' Pension Plan Board
Ontario, Canada
$220K +$195K +538 New
CPP
435
Crow Point Partners
Massachusetts
$219K -$17.8K -49 -8%
MWM
436
Meridian Wealth Management
Kentucky
$215K +$190K +525 New
TSS
437
Two Sigma Securities
New York
$210K -$320K -883 -63%
CAG
438
Csenge Advisory Group
Florida
$209K +$185K +510 New
SCA
439
Sage Capital Advisors
South Dakota
$206K +$183K +504 New
BHA
440
Beech Hill Advisors
New York
$205K -$181K -500 -50%
LA
441
LexAurum Advisors
Kansas
$205K +$181K +500 New
RAM
442
Redmond Asset Management
Virginia
$205K +$181K +500 New
SBIA
443
Sheaff Brock Investment Advisors
Indiana
$205K +$181K +500 New
CF
444
Centaurus Financial
California
$205K +$182K +502 New
RFM
445
Royal Fund Management
Florida
$204K – – –
PIA
446
Piedmont Investment Advisors
North Carolina
$196K +$174K +479 New
NC
447
NewSquare Capital
Pennsylvania
$186K +$159K +440 New
HFM
448
Harvest Fund Management
China
$180K +$23.9K +66 +18%
APA
449
American Portfolios Advisors
New York
$179K +$26.4K +73 +20%
IA
450
IFP Advisors
Florida
$178K +$35.1K +97 +29%
16 17
18
19 20

ABMD Hedge Fund Activity: Q2 2018 in Review

527 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q2 2018, worth a combined $16B — up 40% from $11.5B a quarter earlier.

Buyers outnumbered sellers: 153 funds opened new ABMD positions and 29 closed out — a net gain of 124 holders — while 157 added to existing stakes and 171 trimmed.

The largest buyer was Vanguard Group, adding an estimated $297M. The largest seller was BlackRock, cutting an estimated $315M.

  • 527 institutional investors held Abiomed Inc (ABMD) as of Q2 2018, up from 405 in Q1 2018.
  • Funds reported $16B of Abiomed Inc stock for Q2 2018, up 40% quarter-over-quarter.
  • 153 funds opened new Abiomed Inc positions in Q2 2018 and 29 closed out, a net change of +124 holders.
  • The largest Abiomed Inc buyer in Q2 2018 was Vanguard Group, an estimated $297M added.
  • The largest Abiomed Inc seller in Q2 2018 was BlackRock, an estimated $315M sold.

Based on aggregated 13F filings for Q2 2018.